These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 317653)

  • 41. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus.
    Swaak AJ; Aarden LA; Statius van Eps LW; Feltkamp TE
    Arthritis Rheum; 1979 Mar; 22(3):226-35. PubMed ID: 311204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.
    Jearn LH; Kim DA; Kim TY
    J Rheumatol; 2009 Aug; 36(8):1833-4. PubMed ID: 19671822
    [No Abstract]   [Full Text] [Related]  

  • 43. [The lupus band test. IV. Findings in persistent ANA negative SLE].
    Wollina U; Tanner E; Knopf B
    Dermatol Monatsschr; 1986; 172(11):664-8. PubMed ID: 3545925
    [No Abstract]   [Full Text] [Related]  

  • 44. [Laboratory diagnosis of systemic lupus erythematosus. 1. Quantitative aspects of nuclear phagocytosis in supravital preparation].
    Bauer R; Schütz R
    Z Hautkr; 1977 Nov; 52(22):1119-28. PubMed ID: 74139
    [No Abstract]   [Full Text] [Related]  

  • 45. Lupus band test.
    Olsen TG
    Arch Dermatol; 1978 Jan; 114(1):126-7. PubMed ID: 304335
    [No Abstract]   [Full Text] [Related]  

  • 46. [Correlation between organic changes, antibodies against native DNA and antinuclear antibody titer in patients with systemic lupus erythematosus].
    Marczak M; Kardaszewicz E
    Pol Tyg Lek; 1985 Jun; 40(23):654-6. PubMed ID: 3876550
    [No Abstract]   [Full Text] [Related]  

  • 47. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 48. [Unusual 15-year course of systemic lupus erythematosus with glomerulonephritis].
    Mrowka C; Thoenes GH; Hübner K; Thoenes W
    Internist (Berl); 1992 Nov; 33(11):763-7. PubMed ID: 1478833
    [No Abstract]   [Full Text] [Related]  

  • 49. [Systemic lupus erythematosus (SLE). I. New insights into serology and pathogenesis].
    Feltkamp TE
    Ned Tijdschr Geneeskd; 1974 Feb; 118(5):166-70. PubMed ID: 4596539
    [No Abstract]   [Full Text] [Related]  

  • 50. Polymorphous light erutpion and lupus erythematosus. Differential diagnosis by fluorescent microscopy.
    Fisher DA; Epstein JH; Kay DN; Tuffanelli DL
    Arch Dermatol; 1970 Apr; 101(4):458-61. PubMed ID: 4909553
    [No Abstract]   [Full Text] [Related]  

  • 51. [Anti-DNA antibody, anti-idiotypic antibody and systemic lupus erythematosus].
    Sasaki T
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1159-63. PubMed ID: 2258660
    [No Abstract]   [Full Text] [Related]  

  • 52. [Discussion on the diagnostic criteria of systemic lupus erythematosus--with analysis of 306 cases].
    Zhang NZ
    Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):327-30. PubMed ID: 6982155
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus.
    Weinstein A; Bordwell B; Stone B; Tibbetts C; Rothfield NF
    Am J Med; 1983 Feb; 74(2):206-16. PubMed ID: 6600582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FPIN’s clinical inquiries: antibody testing for systemic lupus erythematosus.
    Gibson K; Goodemote P; Johnson S
    Am Fam Physician; 2011 Dec; 84(12):1407-9. PubMed ID: 22230277
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 1) Systemic lupus erythematosus].
    Kumagai S; Higashi J; Tsunematsu T
    Nihon Rinsho; 1988 Apr; 46(4):867-72. PubMed ID: 3261360
    [No Abstract]   [Full Text] [Related]  

  • 56. Disease activity in systemic lupus erythematosus. Value of laboratory criteria.
    Claudy AL; Touraine JL; Alario A
    Clin Exp Dermatol; 1979 Dec; 4(4):435-43. PubMed ID: 317029
    [No Abstract]   [Full Text] [Related]  

  • 57. Persistent Clq deficiency in a patient with a systemic lupus erythematosus-like syndrome.
    Wara DW; Reiter EO; Doyle NE; Gewurz H; Ammann AJ
    J Pediatr; 1975 May; 86(5):743-5. PubMed ID: 1079532
    [No Abstract]   [Full Text] [Related]  

  • 58. Antinuclear antibodies in the diagnosis of systemic lupus erythematosus.
    Brandstetter RD
    JAMA; 1979 Feb; 241(8):792. PubMed ID: 310897
    [No Abstract]   [Full Text] [Related]  

  • 59. Application, to Japanese patients, of the 1982 American Rheumatism Association revised criteria for the classification of systemic lupus erythematosus.
    Yokohari R; Tsunematsu T
    Arthritis Rheum; 1985 Jun; 28(6):693-8. PubMed ID: 3873947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lupus erythematosus cell preparation-antinuclear factor incongruity. A review of diagnostic tests for systemic lupus erythematosus.
    Koller SR; Johnston CL; Moncure CW
    Am J Clin Pathol; 1976 Sep; 66(3):495-505. PubMed ID: 60880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.